- Home
- ACHV
as 11-21-2024 4:00pm EST
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | SEATTLE |
| Market Cap: | 149.6M | IPO Year: | N/A |
| Target Price: | $14.80 | AVG Volume (30 days): | 116.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.15 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.03 - $5.98 | Next Earning Date: | 11-07-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Achieve Life Sciences Inc. News
ACHV Breaking Stock News: Dive into ACHV Ticker-Specific Updates for Smart Investing
GlobeNewswire
7 days ago
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Zacks Small Cap Research
11 days ago
ACHV: Commercialization in Focus
GuruFocus.com
13 days ago
Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
GlobeNewswire
14 days ago
Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update
GlobeNewswire
a month ago
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024
GlobeNewswire
a month ago
Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting
GlobeNewswire
a month ago
Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline
GlobeNewswire
a month ago
Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting
Compare ACHV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ACHV Achieve Life Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.